Pfizer Gets FDA Emergency Approval for Vaccine in 12-15 Year-Olds

The COVID-19 vaccination effort reached a new high point on Monday as the Food and Drug Administration granted further approval to Pfizer to begin inoculating children from the ages of 12 to 15.

This emergency use authorization makes the Pfizer product the first COVID-19 vaccine that will be allowed to be administered to individuals under the age of 16.

In a study released in March, statistics returns showed high antibody counts and 100 percent efficiency against the coronavirus in the 2,260 adolescents who volunteered.

Former FDA commissioner Scott Gottlieb expressed the effect this news will have on the country’s effort to achieve mass vaccination.

“We’ll pick up about 5 million immediately. I think probably another 5 million, 5-7 million would get vaccinated over the course of the summer before the school year.”